Does McMillan Shakespeare Limited (ASX:MMS) Create Value For Shareholders?

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card!

Today we’ll evaluate McMillan Shakespeare Limited (ASX:MMS) to determine whether it could have potential as an investment idea. To be precise, we’ll consider its Return On Capital Employed (ROCE), as that will inform our view of the quality of the business.

First, we’ll go over how we calculate ROCE. Next, we’ll compare it to others in its industry. And finally, we’ll look at how its current liabilities are impacting its ROCE.

Return On Capital Employed (ROCE): What is it?

ROCE is a measure of a company’s yearly pre-tax profit (its return), relative to the capital employed in the business. In general, businesses with a higher ROCE are usually better quality. Ultimately, it is a useful but imperfect metric. Author Edwin Whiting says to be careful when comparing the ROCE of different businesses, since ‘No two businesses are exactly alike.’

So, How Do We Calculate ROCE?

The formula for calculating the return on capital employed is:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets – Current Liabilities)

Or for McMillan Shakespeare:

0.18 = AU$137m ÷ (AU$887m – AU$143m) (Based on the trailing twelve months to December 2018.)

So, McMillan Shakespeare has an ROCE of 18%.

Check out our latest analysis for McMillan Shakespeare

Does McMillan Shakespeare Have A Good ROCE?

ROCE is commonly used for comparing the performance of similar businesses. Using our data, McMillan Shakespeare’s ROCE appears to be around the 19% average of the Professional Services industry. Independently of how McMillan Shakespeare compares to its industry, its ROCE in absolute terms appears decent, and the company may be worthy of closer investigation.

ASX:MMS Past Revenue and Net Income, June 26th 2019
ASX:MMS Past Revenue and Net Income, June 26th 2019

When considering this metric, keep in mind that it is backwards looking, and not necessarily predictive. ROCE can be deceptive for cyclical businesses, as returns can look incredible in boom times, and terribly low in downturns. This is because ROCE only looks at one year, instead of considering returns across a whole cycle. Future performance is what matters, and you can see analyst predictions in our free report on analyst forecasts for the company.

What Are Current Liabilities, And How Do They Affect McMillan Shakespeare’s ROCE?

Short term (or current) liabilities, are things like supplier invoices, overdrafts, or tax bills that need to be paid within 12 months. Due to the way the ROCE equation works, having large bills due in the near term can make it look as though a company has less capital employed, and thus a higher ROCE than usual. To check the impact of this, we calculate if a company has high current liabilities relative to its total assets.

McMillan Shakespeare has total assets of AU$887m and current liabilities of AU$143m. Therefore its current liabilities are equivalent to approximately 16% of its total assets. Current liabilities are minimal, limiting the impact on ROCE.

The Bottom Line On McMillan Shakespeare’s ROCE

Overall, McMillan Shakespeare has a decent ROCE and could be worthy of further research. McMillan Shakespeare shapes up well under this analysis, but it is far from the only business delivering excellent numbers . You might also want to check this free collection of companies delivering excellent earnings growth.

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: insiders have been buying them).

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.